2025 Investment to Swing Toward I&I, Obesity, More: Experts

Experts Predict 2025 Investments to Focus on I&I and Obesity

Therapeutic mainstays like oncology and neuroscience have hogged the spotlight lately. With flashy billion-dollar acquisitions and groundbreaking drugs for diseases like Alzheimer’s and various cancers, who could look away? Big players like Johnson & Johnson haven’t been shy, forking over a hefty sum of $14.6 billion for neuropsychiatric leader Intra-Cellular Therapies. But wait, 2025 might […]